Previous reports demonstrated that MSI2 is essential for the progression of CML [16]–[18], and the knockdown of another family member, Musashi-1 (MSI1), disrupts the viability of DAOY MB cells and GB cells [28], [29]. This evidence concerns the gene MSI2 and chronic myelogenous leukemia, BCR-ABL1 positive.